AzTrials
AzTrials

Chronic Liver FailureNCT06240832

Aerobic Capacity Muscle Strength and Health Related Quality of Life in Children With Chronic Liver Disease

A study testing Physical therapy exercise in people with Chronic Liver Failure, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Physical therapy program for children with chronic liver disease consist of gait training, strengthening ex for UL\&ll, stretching exercise to improve physical fitness and quality of life Read more about this study

Who is it for?
Ages 7 to 14 years
Conditions the study is for
Chronic Liver Failure
What is being tested?
Physical therapy exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteEgypt
Study dates
22 Jun 2022to 22 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Their age ranged from7 to14 years old.
  • Residence in Cairo to be able to attend the rehabilitation program.
  • Diagnosis of CLD as (Wilson disease, autoimmune hepatitis, chronic cholestasis , ….etc).
  • All children were medically stabled
  • All children had the same socioeconomic status

Who cannot join

  • Complication that prevent children from performing maximal exercise test as fracture of both upper and lower limbs, cardiovascular instability and muscle disease in patient with glycogen storage disease(GSD) or abnormal creatine phosphokinase(CPK).
  • Patients with cognitive and motor disorders as in case of hepatic encephalopathy and or ascites.
  • Patients who underwent liver transplantation.
  • Patient with end stage liver disease.
  • History of variceal bleeding from one month ago or less.
  • No other system disease (chest, cardiac and nervous system).
  • Medical examination no hernia.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo university

    Cairo

Other trials in Egypt

About this study

Physical therapy program for children with chronic liver disease consist of gait training, strengthening ex for UL\&ll, stretching exercise to improve physical fitness and quality of life

Read the detailed description

Intervention study for one group of children diagnosed with chronic liver disease ages more than 6ys, study include assessment and intervention, assessment of 6MWt, grip strength by hand held dynamometer, quadriceps strength by Lafayette, al children subjected to laboratory investigation pre and post of study completion, anthropometric measure, quality of life and fatigue assessment then all children will perform physical therapy program of gait training muscle strengthening for 8 week

Being tested
Physical therapy exercise
Keywords
aerobic capacity, chronic liver disease, muscle strength
Medical subject headings
End Stage Liver Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical therapy exerciseOther

    Also called Designated physical therapy program

    Endurance, strength and stretching training in Chronic liver disease children

Study groups in NCT06240832
Study groupRoleWhat they receive
Aerobic and strength training in children with CLDExperimentalAEROBIC AND STRENGTHENING EXERCISE USING TREADMILL AND WEIGHT TO IMPROVE FUNCTIONAL OUTCOMES IN CHILDREN WITH CHRONIC LIVER DISEASE
Receives: Other: Physical therapy exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. aerobic capacity

    it was assessed by 6 minute walk test(6-MWT) in meter, The distance in meters was recorded at the end of the six minutes.

    Measured: 8week

  2. grip strength

    it was assessed by pneumatic hand held dynamometer ,was measured in pounds per square inch (PSI). The child was sitting on a chair with or without arm rest, back supported, and both feet rested on the floor. The right arm was beside the body, with adducted shoulder, elbow flexed 90°, forearm in neutral position, wrist from 0° to 30° extension, and 0° to 15° of ulnar deviation. Child was instructed to hold and compress the pneumatic handle of dynamometer as much strength as possible with the tested hand

    Measured: 8week

  3. quadriceps strength

    it was assessed by Lafayette hand held dynamometer(LHHD)Child position was sitting on chair with back straight, hip and knee were in 90-degree flexion. LHHD was fixed on distal third of anterior surface of child leg while his/her tested thigh was stabilizing and then the child was instructed to perform maximal isometric knee extension and hold for 6 sec against LHHD sensor pad.

    Measured: 8 week

  4. health related quality of life

    The Arabic version of child self-report Pediatric Quality of Life Inventory core scale version 4 (PedsQI) was used to assess HRQOL. PedsQI core scale designed to measure HRQOL in children and adolescents ages from 2 to18years. Each item of the questionnaire rated based on a rating scale from 0-4. Then, each item score was linearly converted on assessment scale from 0 to 100;0=100, 1=75, 2=50, 3=25, 4=0 then overall score calculated for all domains through dividing all answered items over whole number of items, with higher scores indicate a better HRQOL

    Measured: 8week

  5. fatigue

    It was assessed by the PedsQI multidimensional fatigue scale version 3. It is composed of 3 domains; general fatigue, sleep/rest fatigue and cognitive fatigue,Each item score converted on a scale from 0 to 100: 0=100, 1=75, 2=50, 3=25, 4=0 then overall score calculated for all domains through dividing all answered items over whole number of items, with higher scores indicate lower level of fatigue

    Measured: 8 weeks

Secondary outcomes (10)
  1. hemoglobin

    A blood sample was taken for complete blood count (CBC )hemoglobin

    Measured: 8week

  2. liver enzymes

    A blood sample was taken for liver enzymes (Total bilirubin ,Direct bilirubin ) unit of measure (mg/dl)

    Measured: 8week

  3. minerals

    A blood sample was taken for minerals concentration (sodium Na,potassium K, magnissium M, calciumCa, posphorus P and create) unit of measure (mmol/l)

    Measured: 8week

  4. mid upper arm circumference in centimeter

    assessed by tape measure,the tape was passed around the arm at the mid-point of the upper right arm halfway between the acromion process and the olecranon process

    Measured: 8 weeks

  5. triceps skin fold thickness

    it was assessed by holtain skinfold calipers in millimeter

    Measured: 8 weeks

  6. height in meter (m)

    assessed by stadiometre

    Measured: 8 weeks

  7. weight in kilogrms (Kg)

    assess by electronic scale

    Measured: 8 weeks

  8. body mass index

    height/weight kg/m2

    Measured: 8weeks

  9. mid upper muscle circumference

    assessed by calculators that substract triceps skin fold thickness from mid upper arm circumference

    Measured: 8weeks

  10. mid upper leg circumference in centimetre

    assessed by tape measure at mid -point between iliac crest and mid of patella

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2024
  2. Study start22 Jun 2022
  3. Primary completion22 May 2023
  4. Study completion22 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
One group of children ages more than 6ys will recruited and assessed pre and post of study completion for 12week
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06240832
Sponsor's protocol ID
P. T. REC/012/003479
Status last verified
Jan 2024
First submitted
7 Jan 2024
Last updated
5 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, Ma M, Abraldes JG, Paterson I, Haykowsky MJ, Tandon P. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014 Nov;12(11):1920-6.e2. doi: 10.1016/j.cgh.2014.04.016. Epub 2014 Apr 24.

    PubMed 24768811

Questions about this trial

What is this clinical trial studying?

A study testing Physical therapy exercise in people with Chronic Liver Failure, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

aerobic capacity (time frame: 8week). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06240832, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in